https://www.selleckchem.com/pr....oducts/Deforolimus.h
The most used PIMs were nifedipine, glibenclamide, and sodium diclofenac. The risk factors were polypharmacy (aRR 3.00; 95% CI 1.31-6.88) and diabetes mellitus (aRR 1.57; 95% CI 1.03-2.39). We identified no statistically significant association between survival and the use of PIM. The study highlights the high consumption of PIM among the elderly causing polypharmacy risks. Health professionals working in drug treatment need to be alert to polypharmacy risks to ensure the rational use of medications to prevent adverse reactions and
Gefällt mir
Kommentar
Teilen
